Weixiang Lu
Impact in
- Oncology top 1%
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Lung Cancer Diagnosis and Treatment 3
- Ferroptosis and cancer prognosis 2
- Sarcoma Diagnosis and Treatment 1
- Oncology 5
- CAR-T cell therapy research 1
- Co-authors
- Jianxing He (6 shared papers)Jianfu Li (4 shared papers)Hengrui Liang (4 shared papers)Wenhua Liang (4 shared papers)Caichen Li (3 shared papers)Ke Xu (2 shared papers)Wei‐jie Guan (1 shared paper)Wei Wang (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (2 papers)Annals of Hematology (2 papers)Frontiers in Neurorobotics (1 paper)Annals of Palliative Medicine (1 paper)Critical Reviews in Oncology/Hematology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Weixiang Lu
19 papers receiving 3.3k citations
Weixiang Lu's Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 2.3k
- Infectious Diseases 1.0k
- Radiology, Nuclear Medicine and Imaging 298
- Obstetrics and Gynecology 94
- Neurology 183
Countries citing papers authored by Weixiang Lu
This map shows the geographic impact of Weixiang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixiang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixiang Lu more than expected).
Fields of papers citing papers by Weixiang Lu
This network shows the impact of papers produced by Weixiang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixiang Lu. The network helps show where Weixiang Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weixiang Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China Hit paper breakdown → | 2020 | 3319 |
| 2 | 2021 | 48 | |
| 3 | 2024 | 13 | |
| 4 | 2021 | 10 | |
| 5 | 2024 | 6 | |
| 6 | 2025 | 6 | |
| 7 | 2023 | 5 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 4 | |
| 10 | 2022 | 4 | |
| 11 | 2024 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2024 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2025 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2012 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2023 | 0 |
About Weixiang Lu
Weixiang Lu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Pathology and Forensic Medicine and Immunology, having authored 20 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (3 papers), Ferroptosis and cancer prognosis (2 papers), Acute Myeloid Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Sarcoma Diagnosis and Treatment (1 paper), COVID-19 Clinical Research Studies (1 paper), Congenital Diaphragmatic Hernia Studies (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (2.3k citations), Infectious Diseases (1.0k citations), Radiology, Nuclear Medicine and Imaging (298 citations), Obstetrics and Gynecology (94 citations) and Neurology (183 citations). Weixiang Lu has collaborated with scholars based in China and United States. Frequent co-authors include Jianxing He, Jianfu Li, Hengrui Liang, Wenhua Liang, Caichen Li, Ke Xu, Wei‐jie Guan, Wei Wang, Qing Ai and Shiyue Li. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Annals of Hematology, Frontiers in Neurorobotics, Annals of Palliative Medicine and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.